Literature DB >> 29605150

Inferomedial Hip Center Decreases Failure Rates in Cementless Total Hip Arthroplasty for Crowe II and III Hip Dysplasia.

Chad D Watts1, John R Martin2, Keith A Fehring2, William L Griffin2.   

Abstract

BACKGROUND: We sought to evaluate the outcomes of cementless acetabular components used in patients with Crowe II and III dysplasia, and to compare outcomes between cups placed within vs outside of an "anatomic" zone. Our specific aims were to (1) plot hip centers in these patients at our institution to characterize "anatomic" vs "nonanatomic" positions, (2) evaluate the association between hip center and radiographic loosening, (3) determine whether hip center was associated with acetabular component revision, and (4) compare patient-reported outcome scores between groups.
METHODS: We retrospectively reviewed 88 primary cementless total hip arthroplasties at a mean follow-up of 10 years (range 2-26 years). Patients were 85% female, with a mean age of 44 years (range 28-61 years) and a body mass index of 27 kg/m2 (range 19-42 kg/m2). Medical records and radiographs were reviewed, and a survey was conducted for all patients. Anatomic hip center was defined using the 4-zone system, wherein centers are "anatomic" if they are <1 cm superior and <1 cm lateral to the approximate femoral head center. Cox proportional analyses were used to compare outcomes between groups.
RESULTS: Seventy hips (80%) had an anatomic hip center. Anatomic hips had a lower incidence of radiographic acetabular loosening (0% vs 17%, P = .007) and cup revision (0% vs 28%, P = .0002). There were no differences in Hip Disability and Osteoarthritis Outcome and Joint Replacement Scores (96.2 ± 5 vs 91.9 ± 12, P = .7).
CONCLUSION: The incidence of aseptic loosening and cup revision were lower when hip center was <1 cm superior and 1 cm lateral to the approximate femoral head center.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cup position; developmental hip dysplasia; hip center; hip dysplasia; total hip arthroplasty

Mesh:

Year:  2018        PMID: 29605150     DOI: 10.1016/j.arth.2018.02.039

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Does Cup Position at the High Hip Center or Anatomic Hip Center in THA for Developmental Dysplasia of the Hip Result in Better Harris Hip Scores and Revision Incidence? A Systematic Review.

Authors:  Patrick Stirling; Maria-Roxana Viamont-Guerra; Louise Strom; Antonia F Chen; Mo Saffarini; Luca Nover; Frederic Laude
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

2.  Acetabular Bone Defect in Total Hip Arthroplasty for Crowe II or III Developmental Dysplasia of the Hip: A Finite Element Study.

Authors:  Yinqiao Du; Jun Fu; Jingyang Sun; Guoqiang Zhang; Jiying Chen; Ming Ni; Yonggang Zhou
Journal:  Biomed Res Int       Date:  2020-08-25       Impact factor: 3.411

3.  Anterior Total Hip Arthroplasty With Bulk Femoral Head Autograft in a Patient With Camurati-Engelmann Disease.

Authors:  Adam J Taylor; Robert P Runner; Donald B Longjohn; Soheil Najibi
Journal:  Arthroplast Today       Date:  2021-04-14

4.  Functional and radiographical results of asymmetrically reconstructed total hip arthroplasty in patients with bilateral dysplastic arthritic hips with one hip Crowe II-III and the other Crowe IV: a retrospective cohort study.

Authors:  Junmin Shen; Jingyang Sun; Yinqiao Du; Bohan Zhang; Tiejian Li; Yonggang Zhou
Journal:  J Orthop Traumatol       Date:  2021-03-13

5.  Femoral Head Autograft Can Reliably Reconstruct Dysplastic Acetabula Through the Direct Anterior Approach for Total Hip Arthroplasty.

Authors:  Adam J Taylor; Robert P Runner; Robert D Kay; Soheil Najibi
Journal:  Arthroplast Today       Date:  2022-03-18

6.  High Hip Center Technique in Total Hip Arthroplasty for Crowe Type II-III Developmental Dysplasia: Results of Midterm Follow-up.

Authors:  Junmin Shen; Jingyang Sun; Haiyang Ma; Yinqiao Du; Tiejian Li; Yonggang Zhou
Journal:  Orthop Surg       Date:  2020-08-09       Impact factor: 2.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.